2Stein U,Walther W.Cytokine-mediated reveral of multidrug resis-tance[J].Cytoteh,1998,27(1-3):271-282.
3Haus-Cohen M,Assaraf Y G,Binyamin L,et al.Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment tragment targeted to an extracellular epitope[J].Int J Cancer,2004,109(5):750-758.
5Marzolini C,Paus E,Buclin T,et al.Polymophisms in human MDR1 (P-glycoprotein):recent advances and clinical relevance[J].Clin Phamacol Ther,2004,75(1):13-33.
8Stupp R,Bauer J,Pagani O,et al.Ventricuar arrhythmia and torsade de pointe:dose limiting toxicities of the MDR-modulator S9788 in a phase Ⅰ trial[J].Ann Oncol,1998,9(11):1233-1242.
9Francois H,Catherine V,Pierre D V,et al.In vitro and in vivo reversal of multidrug resistance by GF120918,an acridonecarboxa-mide derivative[J].Cancer Res,1993,53(19):4595-4602.
3Scagliotti GV, Novello S, Selvaggi G. Multidrug resistance in non-small-eell lung cancer I J]. Ann Oneol,1999,10(5 suppl. ) :81 - 84.
4Stein U, Walther W. Cytokine-mediated reveral of multidrug resistance [ J ]. Cytotech, 1998, 27 ( 1/3 ) :271 - 282.
5Teodori E, Dei S, Quidu P, et al. Design, synthesis,and in vitro activity of catamphiphilic reverters of multidrug resistance: discovery of a selective, highly efficacious chemosensitizer with potency in the nanomolar range [ J ]. J Med Chem, 1999, 42 ( 10 ) :1687- 1697.
7Naito M, Tsuruo T. New multidrug-resistance-reversing drugs, MS-209 and SDZ PSC 833 [ J ]. Cancer Chemother Pharmacol, 1997, 40(suppl. ) :20 - 24.
8Solary E, Mannone L, Moreau D, et al. Phase I study of einehonine, a multidrug resistance reversing agent,combined with the CHVP regimen in relapsed and refractory lymphoprtliferative syndromes [ J ]. Leukemia,2000, 14(12) :2085 - 2094.
9Dantzig A, Shepard R, Cao J, et al. Reversal of P-glycoprotein-mediated multidrug resistance by a potent cydopropyldibenzosuberane modulator, LY-335979[J]. Cancer Res, 1996, 56(18) :4171 - 4179.
10Krystyna M, Andrzej BH, Olga W, et al. Compounds that modulate multidrug resistance in cancer cells[J].Cell Biol Mol Lett,2001,6(2A):362- 368.
